Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

company_intel GlaxoSmithKline plc


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$34
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Bexxar Receives Strong Support from FDA Advisory Panel Corixa Corp. GlaxoSmithKline plc
$71
 Subscribers Subscribers
Preview 		2005
 ContractIntelligence Combination Agreement GlaxoSmithKline;
ID Biomedical 		BankUBS Securities
$34
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Corixa and GlaxoSmithKline Announce FDA Approval of Bexxar Corixa;
GlaxoSmithKline 		Michigan
$35
 Subscribers Subscribers
2001
 ContractIntelligence Corixa and GlaxoSmithKline File Suit Against IDEC Pharmaceuticals Corporation for Patent Infringement Corixa;
Coulter Pharma 		GlaxoSmithKline;
Michigan
$35
 Subscribers Subscribers
2001
 ContractIntelligence Corixa and GlaxoSmithKline Issue Statement Regarding IDEC Patent Infringement Corixa Corp. GlaxoSmithKline plc
$38
 Subscribers Subscribers
Preview 		2001
 ContractIntelligence Corixa and GlaxoSmithKline Receive Complete Review Letter Following FDA Evaluation of Bexxar(TM) BLA U.S. Food and Drug Administration;
Corixa 		GlaxoSmithKline
$37
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Corixa and GlaxoSmithKline Report Progress on FDA Review of Bexxar Therapy Application Corixa Corp. GlaxoSmithKline plc
$37
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Corixa Reports Second Quarter Financial Results Corixa;
GlaxoSmithKline 		BankBNY
$37
 Subscribers Subscribers
2002
 ContractIntelligence Exelixis and Glaxosmithkline Form Broad Alliance To Discover and Develop Novel Therapeutics Exelixis;
GlaxoSmithKline 		Protein Design
$40
 Subscribers Subscribers
2004
 ContractIntelligence Exelixis Announces Fourth Quarter and Year-End 2003 Financial Results Bristol-Myers;
Cytokinetics;
Exelixis 		GlaxoSmithKline;
Merck;
Protein Design
$42
 Subscribers Subscribers
Preview 		2003
 For Immediate Release GlaxoSmithKline;
ImmunoGen 		Millennium
$39
 Subscribers Subscribers
Preview 		2003
 For Immediate Release Cima Labs;
GlaxoSmithKline;
Salix Pharma 		Smithkline;
Harvard;
Penn
$70
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Global Clinical Trials Agreement
[Amended and Restated] 		GlaxoSmithKline;
Quest Diagnostic 		Smithkline
$39
 Subscribers Subscribers
Preview 		2003
 ContractIntelligence Guaranteed Convertible Notes aaiPharma;
Acusphere;
Allergan 		Amarin
Entity 2 3 4 5 6
Bank 2 Law Firm 2
$44
 Subscribers Subscribers
Preview 		2007
 ContractIntelligence Heads of Agreement GlaxoSmithKline plc
$39
 Subscribers Subscribers
2003
 ContractIntelligence Human Genome Sciences Reports Financial Results for First Quarter of 2003 GlaxoSmithKline plc Human Genome Sciences Inc.
$38
 Subscribers Subscribers
2002
 ContractIntelligence Immunogen, Inc. Provides Update on Relationship with GlaxoSmithKline And Also on the Status of Trastuzumab-DM1 GlaxoSmithKline plc ImmunoGen, Inc.
$47
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence License and Option Agreement Cardiome Pharma;
Catalytica 		GlaxoSmithKline;
ILEX Oncology
$58
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence License and Option Agreement GlaxoSmithKline plc Oscient Pharmaceuticals Corp.
$66
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence License and Option Agreement GlaxoSmithKline plc